REMX vs. RARE

Last updated Aug 2, 2026

REMX (VanEck Rare Earth and Strategic Metals ETF) is Rare Earth & Strategic Metals fund tracking the MarketVector Global Rare Earth/Strategic Metals Index, while RARE (Ultragenyx Pharmaceutical Inc.) is a stock. Over the past 10 years, REMX returned 5.76%/yr vs -8.91%/yr for RARE. Their 0.23 correlation means their historical movements had little consistent relationship.

Performance

REMX vs. RARE - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in VanEck Rare Earth and Strategic Metals ETF (REMX) and Ultragenyx Pharmaceutical Inc. (RARE). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, REMX achieves a -10.75% return, which is significantly lower than RARE's 8.30% return. Over the past 10 years, REMX has outperformed RARE with an annualized return of 5.76%, while RARE has yielded a comparatively lower -8.91% annualized return.

REMX

• 1D: -0.72%
• 1M: -23.93%
• 6M: -22.96%
• YTD: -10.75%
• 1Y: 36.09%
• 3Y*: -4.84%
• 5Y*: -7.48%
• 10Y*: 5.76%
• ALL TIME*: -5.36%

RARE

• 1D: -4.34%
• 1M: -25.58%
• 6M: 3.49%
• YTD: 8.30%
• 1Y: -12.41%
• 3Y*: -16.59%
• 5Y*: -20.78%
• 10Y*: -8.91%
• ALL TIME*: -4.76%

*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison

Position	Avg. Volume Value (2W)	Avg. Volume Value (1M)	Avg. Volume Value (3M)
RARE Ultragenyx Pharmaceutical Inc.	$49.66M	$56.10M	$61.47M
REMX VanEck Rare Earth and Strategic Metals ETF	$50.08M	$56.30M	$87.87M

REMX vs. RARE - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
REMX VanEck Rare Earth and Strategic Metals ETF	-10.75%	92.95%	-35.02%	-19.18%	-31.13%	79.81%	64.82%	0.74%	-49.63%	82.60%
RARE Ultragenyx Pharmaceutical Inc.	8.30%	-45.33%	-12.02%	3.22%	-44.90%	-39.25%	224.12%	-1.77%	-6.25%	-34.03%

Correlation

The correlation between REMX and RARE is 0.22, which is low. Their historical price movements had little consistent relationship.

	Correlation
Correlation (1Y) Focuses on recent behavior, but can change the most.	0.22
Correlation (3Y) Balances recent behavior with more history.	0.22
Correlation (5Y) Shows whether the relationship held over a longer period.	0.25
Correlation (10Y) Provides a long-term view across more market conditions.	0.25
Correlation (All Time) Calculated using the full available price history since Jan 31, 2014	0.23

Return for Risk

REMX vs. RARE — Risk / Return Rank

Compare historical risk-adjusted metric ranks over the past 12 months.

REMX

REMX Risk / Return Rank: 31
REMX Sharpe Ratio Rank: 30
REMX Sortino Ratio Rank: 34
REMX Omega Ratio Rank: 32
REMX Calmar Ratio Rank: 28
REMX Martin Ratio Rank: 31

RARE

RARE Risk / Return Rank: 40
RARE Sharpe Ratio Rank: 38
RARE Sortino Ratio Rank: 42
RARE Omega Ratio Rank: 44
RARE Calmar Ratio Rank: 39
RARE Martin Ratio Rank: 38

The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

REMX vs. RARE - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for VanEck Rare Earth and Strategic Metals ETF (REMX) and Ultragenyx Pharmaceutical Inc. (RARE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	REMX	RARE	Difference
Sharpe ratio: Return per unit of total volatility	0.74	-0.13	+0.87
Sortino ratio: Return per unit of downside risk	1.29	0.32	+0.97
Omega ratio: Gain probability vs. loss probability	1.15	1.05	+0.10
Calmar ratio: Return relative to maximum drawdown	0.89	-0.18	+1.07
Martin ratio: Return relative to average drawdown	2.75	-0.34	+3.09

REMX vs. RARE - Sharpe Ratio Comparison

The current REMX Sharpe Ratio is 0.74, which is higher than the RARE Sharpe Ratio of -0.13. The chart below compares the historical Sharpe Ratios of REMX and RARE, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

REMX vs. RARE - Drawdown Comparison

The maximum REMX drawdown since its inception was -90.20%, roughly equal to the maximum RARE drawdown of -89.57%. Use the drawdown chart below to compare losses from any high point for REMX and RARE.

Drawdown Indicators

	REMX	RARE	Difference
Max Drawdown Largest peak-to-trough decline	-90.20%	-89.57%	-0.63%
Max Drawdown (1Y) Largest decline over 1 year	-41.03%	-49.37%	+8.34%
Max Drawdown (3Y) Largest decline over 3 years	-58.11%	-68.83%	+10.72%
Max Drawdown (5Y) Largest decline over 5 years	-73.34%	-81.93%	+8.59%
Max Drawdown (10Y) Largest decline over 10 years	-73.34%	-89.57%	+16.23%
Current Drawdown Current decline from peak	-69.79%	-85.96%	+16.17%
Average Drawdown Average peak-to-trough decline	-66.81%	-55.11%	-11.70%
Ulcer Index Depth and duration of drawdowns from previous peaks	13.28%	26.28%	-13.00%

Volatility

REMX vs. RARE - Volatility Comparison

The current volatility for VanEck Rare Earth and Strategic Metals ETF (REMX) is 11.77%, while Ultragenyx Pharmaceutical Inc. (RARE) has a volatility of 13.46%. This indicates that REMX experiences smaller price fluctuations and is considered to be less risky than RARE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	REMX	RARE	Difference
Volatility (1M) Calculated over the trailing 1-month period	11.77%	13.46%	-1.69%
Volatility (6M) Calculated over the trailing 6-month period	37.31%	38.75%	-1.44%
Volatility (1Y) Calculated over the trailing 1-year period	49.87%	67.17%	-17.30%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	40.57%	54.65%	-14.08%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	37.30%	55.21%	-17.91%

Dividends

REMX vs. RARE - Dividend Comparison

REMX's dividend yield for the trailing twelve months is around 1.97%, while RARE has not paid dividends to shareholders.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
RARE Ultragenyx Pharmaceutical Inc.	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
REMX VanEck Rare Earth and Strategic Metals ETF	1.97%	1.76%	2.56%	0.00%	1.56%	5.25%	0.81%	1.64%	12.43%	2.89%	2.23%	4.77%

Frequently Asked Questions

Can I hold both REMX and RARE in my portfolio?

REMX and RARE have a correlation of 0.22, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, REMX or RARE?

RARE has higher volatility (13.46%) compared to REMX (11.77%). In terms of maximum drawdown, REMX dropped -90.20% vs RARE's -89.57%.

Which has better risk-adjusted returns?

REMX currently has the higher Sharpe Ratio (0.74 vs -0.13), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.